BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10352 related articles for article (PubMed ID: 18979999)

  • 1. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of active tuberculous serositis by antigen-specific interferon-gamma response of cavity fluid cells.
    Ariga H; Kawabe Y; Nagai H; Kurashima A; Masuda K; Matsui H; Tamura A; Nagayama N; Akagawa S; Machida K; Hebisawa A; Nakajima Y; Yotsumoto H; Mori T
    Clin Infect Dis; 2007 Dec; 45(12):1559-67. PubMed ID: 18190316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K; Okada K; Harada N; Mori T
    Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research agenda of interferon-gamma release assays].
    Higuchi K; Harada N
    Kekkaku; 2009 Apr; 84(4):173-86. PubMed ID: 19425393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10].
    Harada N; Higuchi K; Sekiya Y; Rothel J; Kitoh T; Mori T
    Kekkaku; 2004 Dec; 79(12):725-35. PubMed ID: 15782618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A view of dynamics of immune responses against tuberculosis infection through QFT].
    Harada N
    Kekkaku; 2011 Jul; 86(7):743-9. PubMed ID: 21922785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
    Kawabe Y
    Kekkaku; 2007 Jan; 82(1):61-6. PubMed ID: 17310783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [QFT test and TST test in diagnosis of TB infection].
    Higuchi K
    Nihon Rinsho; 2011 Aug; 69(8):1378-83. PubMed ID: 21838033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.
    Detjen AK; Keil T; Roll S; Hauer B; Mauch H; Wahn U; Magdorf K
    Clin Infect Dis; 2007 Aug; 45(3):322-8. PubMed ID: 17599309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
    J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
    Manuel O; Kumar D
    Expert Rev Mol Diagn; 2008 May; 8(3):247-56. PubMed ID: 18598104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens.
    Mori T; Sakatani M; Yamagishi F; Takashima T; Kawabe Y; Nagao K; Shigeto E; Harada N; Mitarai S; Okada M; Suzuki K; Inoue Y; Tsuyuguchi K; Sasaki Y; Mazurek GH; Tsuyuguchi I
    Am J Respir Crit Care Med; 2004 Jul; 170(1):59-64. PubMed ID: 15059788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 518.